J0614 Treosulfan - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Treosulfan

Brand Name:

Grafapex

Strength:

50mg

HCPCS:

J0614

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Alkylating Agent

Minor Drug Class:

Alkyl Sulfonate

Oral (Y/N):

No

FDA Approval Year:

2025

FDA Discontinuation Year:

CMS Effective Date:

Sept. 8, 2025

CMS Discontinuation Date:

Status:

In Use